Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The filing references a disclosure made under SEBI's Listing Regulations (Regulation 30 read with Schedule III), which is a standard format companies use to inform the stock exchange about material events such as acquisitions, leadership changes, financial results, or strategic updates. However, the specific details of the announcement were not included in the text provided, so the exact nature of the update cannot be determined from the given information.
No specific impact on shareholders or stock price can be assessed without the actual content of the disclosure. Investors should check the full filing on the NSE/BSE website for details.